Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Blood_product
|
| gptkbp:administeredBy |
Intravenous infusion
|
| gptkbp:alternativeTo |
Human albumin solution
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:compatibleWith |
Replacement of clotting factors
Replacement of immunoglobulins |
| gptkbp:contains |
Albumin
Globulin |
| gptkbp:contraindication |
Severe anemia
|
| gptkbp:derivedFrom |
Human plasma
|
| gptkbp:marketedAs |
Plasmanate
Plasmatein |
| gptkbp:osmoticPressure |
Similar to plasma
|
| gptkbp:sideEffect |
Fever
Allergic reaction Chills |
| gptkbp:storage |
Refrigerated
|
| gptkbp:usedFor |
gptkb:Burns
Shock Treatment of hypovolemia Hypoproteinemia |
| gptkbp:usedIn |
Plasma exchange
|
| gptkbp:bfsParent |
gptkb:PPF
|
| gptkbp:bfsLayer |
7
|
| https://www.w3.org/2000/01/rdf-schema#label |
Plasma Protein Fraction
|